Clinical Trial Site

Lausanne 1005

0 studies enrolling now · 3 studies all time

What they study most

ANCA-Associated Vasculitis, Elevated Urinary Oxalate Levels, High Cardiovascular Risk, Hypertension, Recurrent Calcium Oxalate Kidney Stone Disease

Studies at this site

• Zilebesiran as Add-on Therapy in Patients With High Cardiovascular Risk and Hypertension Not Adequately Controlled by Standard of Care Antihypertensive Medications (KARDIA-3) — Completed
• A Phase 3 Clinical Trial of CCX168 (Avacopan) in Patients With ANCA-Associated Vasculitis — Completed
• A Study to Evaluate Lumasiran in Adults With Recurrent Calcium Oxalate Kidney Stone Disease and Elevated Urinary Oxalate Levels — Stopped early